HIRAKAWA Mayumi
Radiotheranostic Development Unit （Radiation science, medicine and drug development, & industrial applications for radiation）
Academic Affiliations
- The Japanese Society for Immunology (JSI)
- The Japanese Cancer Association (JCA)
No information.
Peer-Reviewed Papers
- Suzuki A, Shigehiro T, Hirakawa M, Hirano R, Tamai M, Akahane K, Okamoto A, Hiroshi Takayanagi,Terashima Y, Ueha S, Kitami T, Takagi D, Keino D, Kawaguchi H, Kato K, Hino M, Inukai T, Yoshimura A, and Ikawa T, Self-reinforcing IL-1β signaling accelerates the development and recurrence of TCF3::HLF-positive B-ALL Blood (in Press)
-
Nagakubo D, Hirakawa M, Iwanami N, Boehm T, Limits to in vivo fate changes of epithelia in thymus and parathyroid by ectopic expression of transcription factors Gcm2 and Foxn1, Scientific Reports, 12, 13554 (2022).
-
Hirakawa M, Nagakubo D, Kanzler B, Avilov S, Krauth B, Happe C, Swann JB, Nusser A, Boehm T, Fundamental parameters of the developing thymic epithelium in the mouse, Scientific Reports, 23;8(1):11095 (2018)
Lectures / Oral Presentations, etc.
Mayumi Hirakawa and Tomokatsu Ikawa “ThymUS international conference 2025, Hawaii Kauai, 27th April – 1st May 2025 Poster presentation “The sex dependent control of non-canonical PRC1 in T cell development”
Mayumi Hirakawa, Lisa Hirano, Tomokatsu Ikawa, The 84th Annual Meeting of the Japanese Cancer Association 25th – 27th Sep 2025, Kanazawa, Japan, Oral presentation “Non canonical Polycomb group proteins epigenetically regulate tumorigenesis during lymphocyte development“
Mayumi Hirakawa, Lisa Hirano, Tomokatsu Ikawa, The 54th Annual Meeting of the Japanese Society for Immunology 10th – 12th December 2025 Oral and poster presentation “Non-canonical PRC1 complexes are required for lymphoid lineage specification “
Awards
- FY 2023: 31st Medical Research Grant (Medicine) – Tsuchiya Foundation
No information.
No information.